Loading stock data…
CLOV
$3.23+0.11 (+3.37%)
Market OpenUpdated 2:40 PM EDT
Clover Health Investments, Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clover Health Investments, Corp. in the Healthcare sector is trading at $3.23. The stock is currently 18% below its 52-week high of $3.92, remaining 27.5% above its 200-day moving average. Technical signals show overbought RSI of 79 and bullish MACD crossover, explaining why CLOV maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 79) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.23
Potential Upside
5%
Whystock Fair Value$3.39
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.31B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.25
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-13.96%
Volume
Today's trading volume
8.04M
Recent News
Clover Health Investments And 2 Other Insider Picks For Growth
Over the last 7 days, the United States market has risen by 2.2%, contributing to a substantial 31% climb over the past year, with earnings expected to grow by 17% annually. In such an environment, stocks with high insider ownership can be appealing as they often indicate confidence from those closest to the company’s operations and potential for growth, making them noteworthy considerations for investors seeking opportunities in this thriving market.
A Look At Clover Health (CLOV) Valuation After Profitability Return And Medicare Advantage Growth
Why Clover Health’s latest earnings matter for shareholders Clover Health Investments (CLOV) sparked fresh attention after first quarter 2026 results showed a return to profitability, with US$27.3 million in net income and Medicare Advantage membership reaching about 156,000 members. See our latest analysis for Clover Health Investments. The strong first quarter has come alongside a sharp shift in sentiment, with a 48.4% 30 day share price return and a 32.4% 90 day share price return,...
Clover Health (CLOV) Q1 2026 Earnings Transcript
Entering 2026, our first quarter results demonstrate how market-leading growth, GAAP net income profitability and full risk can scale together in Medicare Advantage. Coming into 2026, outside of special needs and employer retiree plans, Clover is now the largest PPO in New Jersey. Also, as we attract and retain more members under our technology-driven care model, we expect that to translate into continued earnings expansion.
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initiatives boost profitability.
Clover Health Investments, Corp. Q1 2026 Earnings Call Summary
Moby summary of Clover Health Investments, Corp.'s Q1 2026 earnings call